{"id":"https://openalex.org/W2954370095","doi":"https://doi.org/10.1158/1538-7445.am2019-1106","title":"Abstract 1106: Co-administration of the iRGD tumor-penetrating peptide improves the tumor immunostimulatory effects of low-dose IL-2","display_name":"Abstract 1106: Co-administration of the iRGD tumor-penetrating peptide improves the tumor immunostimulatory effects of low-dose IL-2","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2954370095","doi":"https://doi.org/10.1158/1538-7445.am2019-1106","mag":"2954370095"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-1106","doi":"https://doi.org/10.1158/1538-7445.am2019-1106","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-1106","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063879719","display_name":"Harri A. J\u00e4rvel\u00e4inen","orcid":"https://orcid.org/0000-0003-2458-6547","observed_orcids":["https://orcid.org/0000-0003-2458-6547"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harri Jarvelainen","raw_affiliation_strings":["1DrugCendR Inc., La Jolla, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1DrugCendR Inc., La Jolla, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046764038","display_name":"Gregory P. Botta","orcid":"https://orcid.org/0000-0001-9606-4508","observed_orcids":["https://orcid.org/0000-0001-9606-4508"]},"institutions":[{"id":"https://openalex.org/I188891513","display_name":"Sanford Burnham Prebys Medical Discovery Institute","ror":"https://ror.org/03m1g2s55","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I188891513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory P. Botta","raw_affiliation_strings":["2Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA","institution_ids":["https://openalex.org/I188891513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006429267","display_name":"Tatiana Hurtado de Mendoza","orcid":"https://orcid.org/0000-0003-3805-9254","observed_orcids":["https://orcid.org/0000-0003-3805-9254"]},"institutions":[{"id":"https://openalex.org/I188891513","display_name":"Sanford Burnham Prebys Medical Discovery Institute","ror":"https://ror.org/03m1g2s55","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I188891513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tatiana Hurtado De Mendoza","raw_affiliation_strings":["2Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA","institution_ids":["https://openalex.org/I188891513"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103263796","display_name":"Erkki Ruoslahti","orcid":"https://orcid.org/0000-0001-6588-1249","observed_orcids":["https://orcid.org/0000-0001-6588-1249"]},"institutions":[{"id":"https://openalex.org/I188891513","display_name":"Sanford Burnham Prebys Medical Discovery Institute","ror":"https://ror.org/03m1g2s55","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I188891513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erkki Ruoslahti","raw_affiliation_strings":["2Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA","institution_ids":["https://openalex.org/I188891513"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"1106","last_page":"1106"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7993000149726868,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7993000149726868,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.15530000627040863,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/irgd-peptide","display_name":"iRGD peptide","score":0.9520000219345093},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.902999997138977},{"id":"https://openalex.org/keywords/tumor-penetrating-peptide","display_name":"tumor-penetrating peptide","score":0.8240000009536743},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.8510000109672546},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9089999794960022},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.9480000138282776},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.5680000185966492},{"id":"https://openalex.org/keywords/4t1-cells","display_name":"4T1 cells","score":0.8360000252723694},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.6060000061988831},{"id":"https://openalex.org/keywords/tumor-penetration","display_name":"tumor penetration","score":0.4830000102519989},{"id":"https://openalex.org/keywords/anti-pd-1-resistance","display_name":"anti-PD-1 resistance","score":0.7680000066757202},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6023373007774353},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5967181921005249},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5899237990379333},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5558800101280212},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5525140166282654},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5380468368530273},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5073742270469666},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4919454753398895},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.45844152569770813},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41141244769096375},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3813280165195465},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3401221036911011},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.24473246932029724},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16703546047210693},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10822132229804993},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0668478012084961}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-1106","doi":"https://doi.org/10.1158/1538-7445.am2019-1106","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-1106","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8700000047683716,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2763652643","https://openalex.org/W2960238132","https://openalex.org/W2917116184","https://openalex.org/W7149127542","https://openalex.org/W7223203559","https://openalex.org/W4385567523","https://openalex.org/W4392558605","https://openalex.org/W2923720633","https://openalex.org/W2980703711","https://openalex.org/W2762470830"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Recombinant":[2],"IL-2":[3,96,138,192,221,262,274,307,324,366],"at":[4,255],"high":[5],"doses":[6,190,272],"is":[7,275],"an":[8,236,295],"effective":[9],"immunotherapy":[10],"treatment":[11,267],"for":[12,141,147,153,318,374],"various":[13,51,75],"types":[14,52],"of":[15,39,50,53,74,92,108,176,191,232,247,273,277,321,354,364,370],"solid":[16,326],"tumors.":[17],"However,":[18,217],"its":[19],"clinical":[20],"utility":[21],"has":[22],"been":[23],"limited":[24],"by":[25,103,254],"serious":[26],"mechanism-based":[27],"side-effects.":[28],"The":[29,165,265,305],"clinical-stage":[30],"iRGD":[31,69,93,140,269,312,356],"peptide":[32,358],"specifically":[33],"targets":[34],"tumors":[35,121],"and,":[36],"via":[37],"activation":[38],"the":[40,59,71,99,106,114,162,174,200,245,280,298,319,322,334,355,360,371],"\u2018CendR\u2019":[41],"trans-tissue":[42],"transport":[43],"pathway,":[44],"increases":[45],"tumor":[46,79,100,201,281,327,361],"penetration":[47],"and":[48,167,181,185,235,270,301],"accumulation":[49],"co-administered":[54,223],"drugs.":[55],"By":[56],"selectively":[57],"increasing":[58,104],"drug":[60],"delivery":[61],"into":[62],"tumors,":[63],"but":[64,202],"not":[65],"to":[66,172,196,214,259,332,337],"normal":[67],"tissues,":[68],"potentiates":[70],"pharmacological":[72],"activity":[73],"anti-cancer":[76],"agents":[77],"within":[78,199],"tissue,":[80],"while":[81,292],"reducing":[82],"their":[83],"toxicities.":[84],"In":[85],"this":[86],"study":[87],"we":[88,226],"investigate":[89],"whether":[90],"co-administration":[91,313],"with":[94,131,224,268,311],"low-dose":[95,365],"can":[97],"improve":[98],"immune":[101,282],"microenvironment":[102,283],"in":[105,125,206,238,297,325],"ratios":[107],"tumor-killing":[109],"effector":[110,210,240,299],"CD8":[111,182,209,248,302],"cells":[112,251,289],"vs.":[113],"immunosuppressive":[115,286],"T-regulatory":[116],"cells.":[117,187,242],"Methods:":[118],"Subcutaneous":[119],"breast":[120],"(4T1)":[122],"were":[123,129,145,170,194,290],"generated":[124],"immunocompetent":[126],"mice.":[127],"Mice":[128],"treated":[130],"either":[132],"vehicle":[133,215],"control,":[134],"iRGD,":[135,225],"IL-2,":[136],"or":[137,150,208],"+":[139],"5":[142],"days.":[143],"Tumors":[144],"preserved":[146],"immunohistochemistry":[148],"(IHC)":[149],"enzymatically":[151],"digested":[152],"fluorescence":[154],"activated":[155],"cell":[156],"sorting":[157],"(FACS)":[158],"16":[159],"hours":[160],"after":[161],"last":[163],"dosing.":[164],"FACS":[166],"IHC":[168],"panels":[169],"designed":[171],"detect":[173],"percentage":[175,231],"total":[177],"T":[178,183,211,233,241,287],"cells,":[179,184,212],"CD4":[180,207,239,300],"Treg":[186,250],"Results:":[188],"Low":[189,219],"alone":[193],"found":[195],"increase":[197,237,296],"Tregs":[198],"had":[203],"no":[204],"effect":[205],"compared":[213,258],"treatment.":[216],"when":[218],"dose":[220,261],"was":[222,252,294],"observed":[227],"a":[228,330],"significantly":[229],"lower":[230],"regs":[234],"More":[243],"importantly":[244],"ratio":[246],"/":[249],"increased":[253],"least":[256],"10-fold,":[257],"low":[260,271],"alone.":[263],"Conclusions:":[264],"combination":[266],"capable":[276],"favorably":[278],"altering":[279],"such":[284],"that":[285],"reg":[288],"reduced,":[291],"there":[293],"T-cell":[303],"populations.":[304],"tumor-selective":[306],"pharmacology":[308],"benefit":[309],"obtained":[310],"may":[314],"provide":[315],"new":[316],"options":[317],"use":[320],"well-validated":[323],"patients,":[328],"including":[329],"strategy":[331],"overcome":[333],"primary":[335],"resistance":[336],"PD-1":[338],"blockade.":[339],"Citation":[340],"Format:":[341],"Harri":[342],"Jarvelainen,":[343],"Gregory":[344],"P.":[345],"Botta,":[346],"Tatiana":[347],"Hurtado":[348],"De":[349],"Mendoza,":[350],"Erkki":[351],"Ruoslahti.":[352],"Co-administration":[353],"tumor-penetrating":[357],"improves":[359],"immunostimulatory":[362],"effects":[363],"[abstract].":[367],"In:":[368],"Proceedings":[369],"American":[372],"Association":[373],"Cancer":[375,389],"Research":[376],"Annual":[377],"Meeting":[378],"2019;":[379],"2019":[380],"Mar":[381],"29-Apr":[382],"3;":[383],"Atlanta,":[384],"GA.":[385],"Philadelphia":[386],"(PA):":[387],"AACR;":[388],"Res":[390],"2019;79(13":[391],"Suppl):Abstract":[392],"nr":[393],"1106.":[394]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2019-07-12T00:00:00"}